Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: My forecast

You mean EPS $ 0.25?

Yes, your $180m plus $20m, for $200m, with $100 to PTSC, gives an upper EPS of $0.25, but I still believe that the EPS will be not less than $1.00, for the year.

Be well

Share
New Message
Please login to post a reply